< Back to previous page
Researcher
Peter Vandenberghe
- Disciplines:Genetics, Systems biology, Medical imaging and therapy, Molecular and cell biology, Other paramedical sciences
Affiliations
- Laboratory for Genetics of Malignant Disorders (Division)
Responsible
From1 Jan 2008 → Today - Department of Human Genetics (Department)
Member
From1 Apr 2009 → Today
Projects
1 - 10 of 17
- PhD project to identify the immune signature after CAR T-cells treatment.From5 Nov 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- DIPITO: valorisation of deep immune profiling and novel immunotherapeutics for oncology.From1 Oct 2021 → TodayFunding: IOF - mandates
- In-depth investigation of patient immune signature after CD19 CAR T-cell therapyFrom1 Mar 2021 → TodayFunding: Foundations, funds and other with scientific goal
- Integrated PK/PM Model-based Medication Dosing Assist App(lication) in KlinischWerkStation (KWS). Validation Studies of Tacrolimus in (Solid) Organ TransplantationFrom1 Jan 2021 → TodayFunding: IOF - technology validation in lab
- Mastocytosis and Hymenoptera Venom Allergy - Unraveling the enigmatic link between two unusual diseasesFrom1 Nov 2020 → TodayFunding: BOF - doctoral mandates
- Tracking Multiple Myeloma by low-pass sequencing of circulating cell free DNAFrom1 Mar 2019 → 1 Mar 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Circulating cell-free DNA as an alternative gateway to the genetic features of multiple myeloma and as a surrogate marker for disease burden in multiple myeloma.From1 Mar 2019 → TodayFunding: Nonprofit institution or equivalents
- Circulating cell-free DNA: a novel gateway to the genome of Hodgkin/Reed-Sternberg cells in Hodgkin Lymphoma?From1 Jan 2017 → 31 Dec 2020Funding: Foundations, funds and other with scientific goal
- Circulating cell-free DNA: a novel gateway to the genome of Hodgkin/Reed-Sternberg cells in Hodgkin Lymphoma?From1 Jan 2016 → 31 Dec 2019Funding: FWO research project
- The molecular pathogenesis of essential thrombocythemia: identification of novel signal transduction pathways and novel driver mutations.From1 Jan 2015 → 31 Dec 2018Funding: FWO research project
Publications
1 - 10 of 202
- t(9;12)(q22;p13) ETV6::SYK: A new recurrent cytogenetic aberration and tyrosine kinase gene fusion in myeloid or lymphoid neoplasms associated with eosinophilia(2023)
Authors: Koen Debackere, Lucienne Michaux, Peter Vandenberghe
Pages: 665 - 668 - t(1;7;22)(p13;q21;q13) is a novel 3-way variant of t(1;22)(p13;q13) neonatal acute megakaryoblastic leukemia: A case report(2023)
Authors: Julie Messiaen, Anne Uyttebroeck, Peter Vandenberghe, Nancy Boeckx, Sandra Jacobs
- Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma.(2023)
Authors: Peter Vandenberghe
Pages: 647 - Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes(2023)
Authors: Peter Vandenberghe
Pages: 47 - 59 - Circulating cell-free DNA: a novel gateway to the genome of Hodgkin lymphoma(2022)
Authors: Lieselot Buedts, Peter Vandenberghe
- Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets(2022)
Authors: Huiwen Che, Liesbeth Lenaerts, Kris Van Den Bogaert, Ruben Heremans, Agnieszka Wozniak, Christophe Dooms, Els Wauters, Sigrid Hatse, Kevin Punie, Patrick Neven, et al.
Pages: 1164 - 1176 - Advanced systemic mastocytosis: an uncommon cause of chronic diarrhea and weight loss(2022)
Authors: Timothy Devos, Thomas Tousseyn, Nancy Boeckx, Lucienne Michaux, Peter Vandenberghe
Pages: 84 - 91 - Combined lenalidomide/bortezomib for multiple myeloma complicated by fulminant myocarditis: a rare case report of widely used chemotherapy(2022)
Authors: Peter Vandenberghe, Michel Delforge, Christophe Vandenbriele
- Abstracts from the 2022 Tandem Meetings of ASTCT and CIBMTR, April 23-26, 2022 Abstracts(2022)
Authors: Peter Vandenberghe
Pages: S1 - S486 - Overactive WASp in X-linked neutropenia leads to aberrant B-cell division and accelerated plasma cell generation(2022)
Authors: Peter Vandenberghe
Pages: 1069 - 1084